239 related articles for article (PubMed ID: 20464154)
1. [Thalidomide used by patients with erythema nodosum leprosum].
Valente Mdo S; Vieira JL
Rev Soc Bras Med Trop; 2010; 43(2):201-4. PubMed ID: 20464154
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide levels in patients with erythema nodosum leprosum.
Vieira JL; Valente Mdo S
Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of erythema nodosum leprosum using thalidomide].
Sheskin J
Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
[No Abstract] [Full Text] [Related]
5. Does thalidomide have a role in leprosy?
Crawford CL
Lancet; 2004 Jun; 363(9424):1911. PubMed ID: 15183644
[No Abstract] [Full Text] [Related]
6. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
Upputuri B; Pallapati MS; Tarwater P; Srikantam A
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
[TBL] [Abstract][Full Text] [Related]
7. Elevated platelet counts and thrombocytosis in erythema nodosum leprosum.
Rea TH
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):167-73. PubMed ID: 12483964
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide in the treatment of leprosy.
Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
[TBL] [Abstract][Full Text] [Related]
9. Preparing for thalidomide's comeback.
Vanchieri C
Ann Intern Med; 1997 Nov; 127(10):951-2. PubMed ID: 9446509
[No Abstract] [Full Text] [Related]
10. Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction.
Hebe Petiti-Martin G; Villar-Buill M; de la Hera I; Fuertes L; Burgués-Calderón M; Rivera-Díaz R; Vanaclocha F
Actas Dermosifiliogr; 2013 Jan; 104(1):67-70. PubMed ID: 22705284
[TBL] [Abstract][Full Text] [Related]
11. No role for thalidomide in the treatment of leprosy.
Crawford CL
J Infect Dis; 2006 Jun; 193(12):1743-4; author reply 1744-5. PubMed ID: 16703522
[No Abstract] [Full Text] [Related]
12. [Bullous erythema nodosum leprosum. A case report in French Guiana].
Couppié P; Sainte-Marie D; About V; Heid E; Pradinaud R
Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
[TBL] [Abstract][Full Text] [Related]
13. Interventions for erythema nodosum leprosum.
Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
[TBL] [Abstract][Full Text] [Related]
14. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
[TBL] [Abstract][Full Text] [Related]
15. [Japanese guideline on thalidomide usage in the management of erythema nodosum leprosum].
Ishii N; Ishida Y; Okano Y; Ozaki M; Gidoh M; Kumano K; Goto M; Nogami R; Hatano K; Yamada A; Yotsu RR
Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):275-85. PubMed ID: 21941834
[TBL] [Abstract][Full Text] [Related]
16. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy.
Sales AM; de Matos HJ; Nery JA; Duppre NC; Sampaio EP; Sarno EN
Braz J Med Biol Res; 2007 Feb; 40(2):243-8. PubMed ID: 17273661
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T
Hautarzt; 2001 Oct; 52(10 Pt 2):966-9. PubMed ID: 11715395
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
[TBL] [Abstract][Full Text] [Related]
19. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
20. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature.
Fabi SG; Hill C; Witherspoon JN; Boone SL; West DP
J Drugs Dermatol; 2009 Aug; 8(8):765-9. PubMed ID: 19663116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
